LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 44.42 | 17.25 | 3812 | 3895 | 0.9785 | 0.9945 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 44.42 | 17.25 | 3941 | 3895 | 1.0116 | 1.0030 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 44.42 | 17.25 | 2861 | 3895 | 0.7344 | 0.9226 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 44.42 | 17.25 | 4157 | 3895 | 1.0671 | 1.0167 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 46.39 | 17.25 | 3538 | 4141 | 0.8543 | 0.9606 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 46.39 | 17.25 | 4288 | 4141 | 1.0354 | 1.0088 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 46.39 | 17.25 | 2883 | 4141 | 0.6961 | 0.9104 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 46.39 | 17.25 | 4657 | 4141 | 1.1245 | 1.0299 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 48.36 | 17.25 | 3416 | 4390 | 0.7781 | 0.9382 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 48.36 | 17.25 | 4592 | 4390 | 1.0459 | 1.0113 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 48.36 | 17.25 | 2579 | 4390 | 0.5874 | 0.8712 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 48.36 | 17.25 | 4965 | 4390 | 1.1309 | 1.0310 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 50.33 | 17.25 | 3287 | 4651 | 0.7067 | 0.9158 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 50.33 | 17.25 | 4885 | 4651 | 1.0503 | 1.0122 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 50.33 | 17.25 | 2402 | 4651 | 0.5164 | 0.8428 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 50.33 | 17.25 | 5269 | 4651 | 1.1328 | 1.0311 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 52.30 | 17.25 | 3535 | 4798 | 0.7367 | 0.9261 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 52.30 | 17.25 | 5250 | 4798 | 1.0941 | 1.0223 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 52.30 | 17.25 | 1580 | 4798 | 0.3293 | 0.7443 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 52.30 | 17.25 | 5713 | 4798 | 1.1906 | 1.0434 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 54.27 | 17.25 | 2954 | 4884 | 0.6048 | 0.8803 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 54.27 | 17.25 | 5682 | 4884 | 1.1634 | 1.0375 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 54.27 | 17.25 | 2158 | 4884 | 0.4418 | 0.8092 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 54.27 | 17.25 | 6141 | 4884 | 1.2574 | 1.0570 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 56.24 | 17.25 | 2924 | 4929 | 0.5932 | 0.8760 | MN20160310_N02 | E03 |